
Elli Peselev
Examiner (ID: 18809)
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1673, 1803, 1211, 1203, 1802, 1621, 1623, 2899 |
| Total Applications | 2819 |
| Issued Applications | 1829 |
| Pending Applications | 143 |
| Abandoned Applications | 853 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6675018
[patent_doc_number] => 20030060621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-27
[patent_title] => 'Process for preparing indolopyrrolocarbazole derivatives, intermediates therefor, and preparation process of the intermediates'
[patent_app_type] => new
[patent_app_number] => 10/203088
[patent_app_country] => US
[patent_app_date] => 2002-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11568
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20030060621.pdf
[firstpage_image] =>[orig_patent_app_number] => 10203088
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/203088 | Process for preparing indolopyrrolocarbazole derivatives, intermediates therefor, and preparation process of the intermediates | Aug 5, 2002 | Issued |
Array
(
[id] => 7629726
[patent_doc_number] => 06818630
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-11-16
[patent_title] => 'Biologically active materials'
[patent_app_type] => B1
[patent_app_number] => 10/018608
[patent_app_country] => US
[patent_app_date] => 2002-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 2857
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/818/06818630.pdf
[firstpage_image] =>[orig_patent_app_number] => 10018608
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/018608 | Biologically active materials | Jul 29, 2002 | Issued |
Array
(
[id] => 1169670
[patent_doc_number] => 06753318
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-06-22
[patent_title] => '6,11-4-carbon bridged erythromycin derivatives'
[patent_app_type] => B1
[patent_app_number] => 10/205357
[patent_app_country] => US
[patent_app_date] => 2002-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18995
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1526
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/753/06753318.pdf
[firstpage_image] =>[orig_patent_app_number] => 10205357
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/205357 | 6,11-4-carbon bridged erythromycin derivatives | Jul 24, 2002 | Issued |
Array
(
[id] => 1189425
[patent_doc_number] => 06734292
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-05-11
[patent_title] => 'Pseudoerythromycin derivatives'
[patent_app_type] => B1
[patent_app_number] => 10/088965
[patent_app_country] => US
[patent_app_date] => 2002-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8809
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/734/06734292.pdf
[firstpage_image] =>[orig_patent_app_number] => 10088965
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/088965 | Pseudoerythromycin derivatives | Jul 24, 2002 | Issued |
Array
(
[id] => 7611192
[patent_doc_number] => 06841664
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-01-11
[patent_title] => '6,11-4-carbon bridged ketolides'
[patent_app_type] => utility
[patent_app_number] => 10/205018
[patent_app_country] => US
[patent_app_date] => 2002-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19482
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/841/06841664.pdf
[firstpage_image] =>[orig_patent_app_number] => 10205018
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/205018 | 6,11-4-carbon bridged ketolides | Jul 24, 2002 | Issued |
Array
(
[id] => 6651433
[patent_doc_number] => 20030105066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Nitrate salts of antimicrobial agents'
[patent_app_type] => new
[patent_app_number] => 10/181424
[patent_app_country] => US
[patent_app_date] => 2002-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15800
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20030105066.pdf
[firstpage_image] =>[orig_patent_app_number] => 10181424
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/181424 | Nitrate salts of antimicrobial agents | Jul 23, 2002 | Issued |
Array
(
[id] => 6736030
[patent_doc_number] => 20030013665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-16
[patent_title] => 'Novel macrolide antibiotics'
[patent_app_type] => new
[patent_app_number] => 10/206652
[patent_app_country] => US
[patent_app_date] => 2002-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14361
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20030013665.pdf
[firstpage_image] =>[orig_patent_app_number] => 10206652
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/206652 | Macrolide antibiotics | Jul 23, 2002 | Issued |
Array
(
[id] => 1056589
[patent_doc_number] => 06855813
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-02-15
[patent_title] => 'Process for the preparation of azithromycin monohydrate'
[patent_app_type] => utility
[patent_app_number] => 10/197902
[patent_app_country] => US
[patent_app_date] => 2002-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1455
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/855/06855813.pdf
[firstpage_image] =>[orig_patent_app_number] => 10197902
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/197902 | Process for the preparation of azithromycin monohydrate | Jul 18, 2002 | Issued |
Array
(
[id] => 7629731
[patent_doc_number] => 06818625
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-11-16
[patent_title] => 'Method for increasing survival rate of cells in animal cell culture under hypoxia condition'
[patent_app_type] => B2
[patent_app_number] => 10/181221
[patent_app_country] => US
[patent_app_date] => 2002-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 2984
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/818/06818625.pdf
[firstpage_image] =>[orig_patent_app_number] => 10181221
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/181221 | Method for increasing survival rate of cells in animal cell culture under hypoxia condition | Jul 11, 2002 | Issued |
Array
(
[id] => 1256717
[patent_doc_number] => 06667393
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-12-23
[patent_title] => 'Azalide antibiotic compositions'
[patent_app_type] => B2
[patent_app_number] => 10/194718
[patent_app_country] => US
[patent_app_date] => 2002-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14429
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/667/06667393.pdf
[firstpage_image] =>[orig_patent_app_number] => 10194718
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/194718 | Azalide antibiotic compositions | Jul 10, 2002 | Issued |
Array
(
[id] => 7265322
[patent_doc_number] => 20040242858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Method for producing novel spinosyn derivatives'
[patent_app_type] => new
[patent_app_number] => 10/483543
[patent_app_country] => US
[patent_app_date] => 2004-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7863
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20040242858.pdf
[firstpage_image] =>[orig_patent_app_number] => 10483543
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/483543 | Method for producing novel spinosyn derivatives | Jul 7, 2002 | Issued |
Array
(
[id] => 6761904
[patent_doc_number] => 20030125266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'C12 Modified erythromycin macrolides and ketolides having antibacterial activity'
[patent_app_type] => new
[patent_app_number] => 10/190431
[patent_app_country] => US
[patent_app_date] => 2002-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57985
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20030125266.pdf
[firstpage_image] =>[orig_patent_app_number] => 10190431
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/190431 | C12 modified erythromycin macrolides and ketolides having antibacterial activity | Jul 2, 2002 | Issued |
Array
(
[id] => 6721321
[patent_doc_number] => 20030055011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'Method of using emamectin to treat fish parasites'
[patent_app_type] => new
[patent_app_number] => 10/188939
[patent_app_country] => US
[patent_app_date] => 2002-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7332
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20030055011.pdf
[firstpage_image] =>[orig_patent_app_number] => 10188939
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/188939 | Method of using emamectin to treat fish parasites | Jul 2, 2002 | Abandoned |
Array
(
[id] => 7367444
[patent_doc_number] => 20040006043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-08
[patent_title] => 'Methods, pharmaceutical compositions and pharmaceutical kits for enhancing the therapeutic efficiency of cancer chemotherapeutic agents'
[patent_app_type] => new
[patent_app_number] => 10/187362
[patent_app_country] => US
[patent_app_date] => 2002-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12463
[patent_no_of_claims] => 166
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0006/20040006043.pdf
[firstpage_image] =>[orig_patent_app_number] => 10187362
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/187362 | Methods, pharmaceutical compositions and pharmaceutical kits for enhancing the therapeutic efficiency of cancer chemotherapeutic agents | Jul 1, 2002 | Abandoned |
Array
(
[id] => 6779172
[patent_doc_number] => 20030050254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Derivatives of erythromycin, their preparation process and their use as medicaments'
[patent_app_type] => new
[patent_app_number] => 10/188394
[patent_app_country] => US
[patent_app_date] => 2002-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3258
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0050/20030050254.pdf
[firstpage_image] =>[orig_patent_app_number] => 10188394
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/188394 | Derivatives of erythromycin, their preparation process and their use as medicaments | Jul 1, 2002 | Issued |
Array
(
[id] => 6756544
[patent_doc_number] => 20030004321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-02
[patent_title] => 'Glycosylated analogs of fusidic acid'
[patent_app_type] => new
[patent_app_number] => 10/189242
[patent_app_country] => US
[patent_app_date] => 2002-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 19715
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20030004321.pdf
[firstpage_image] =>[orig_patent_app_number] => 10189242
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/189242 | Glycosylated analogs of fusidic acid | Jul 1, 2002 | Issued |
Array
(
[id] => 1105230
[patent_doc_number] => 06812216
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-11-02
[patent_title] => '11-C-substituted derivatives of clarithromycin'
[patent_app_type] => B2
[patent_app_number] => 10/178991
[patent_app_country] => US
[patent_app_date] => 2002-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16530
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1004
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/812/06812216.pdf
[firstpage_image] =>[orig_patent_app_number] => 10178991
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/178991 | 11-C-substituted derivatives of clarithromycin | Jun 24, 2002 | Issued |
Array
(
[id] => 1271762
[patent_doc_number] => 06653469
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-25
[patent_title] => 'Antibiotic purification method'
[patent_app_type] => B1
[patent_app_number] => 10/176193
[patent_app_country] => US
[patent_app_date] => 2002-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11845
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/653/06653469.pdf
[firstpage_image] =>[orig_patent_app_number] => 10176193
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/176193 | Antibiotic purification method | Jun 19, 2002 | Issued |
Array
(
[id] => 7672921
[patent_doc_number] => 20040180858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-16
[patent_title] => 'Water-soluble antibiotic comprising an amino sugar, in the form of a polysaccharide conjugate'
[patent_app_type] => new
[patent_app_number] => 10/481597
[patent_app_country] => US
[patent_app_date] => 2003-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4476
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 29
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20040180858.pdf
[firstpage_image] =>[orig_patent_app_number] => 10481597
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/481597 | Water-soluble antibiotic comprising an amino sugar, in the form of a polysaccharide conjugate | Jun 18, 2002 | Issued |
Array
(
[id] => 6721552
[patent_doc_number] => 20030055242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'Process for the production of perbenzylated 1-O-glycosides'
[patent_app_type] => new
[patent_app_number] => 10/174508
[patent_app_country] => US
[patent_app_date] => 2002-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9138
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20030055242.pdf
[firstpage_image] =>[orig_patent_app_number] => 10174508
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/174508 | Process for the production of perbenzylated 1-O-glycosides | Jun 18, 2002 | Issued |